Molecular Subtypes of Endometrial Cancers: Approaches and Considerations for Testing

 

This presentation will provide you with the knowledge to approach molecular testing of endometrial cancers with confidence. Focusing on the TCGA molecular classifications of endometrial cancers and the benefits and challenges that have resulted from that study. Practical knowledge and shortcomings about the testing modalities used to classify tumors will be covered. We will also touch on some of the major clinical trials and treatment options for specific tumor types.

Originally published on February 4, 2025

Lecture Presenter

Valarie McMurtry, MD, PhD

Valarie McMurtry, MD, PhD

Fellow, Cytopathology
University of Utah School of Medicine

Dr. Valarie McMurtry completed her undergraduate degree at the University of Oklahoma, followed by her medical degree and doctorate degree from Louisiana State University. Dr. McMurtry is certified by the American Board of Pathology in anatomic and clinical pathology.

Objectives

After this presentation, participants will be able to:

  • Discuss the reasoning and rationale for developing a molecular-based classification of endometrial cancers
  • Select correct testing and order of testing for clinical situations
  • Describe the testing considerations for each molecular classification
  • Discuss the recurrent genetic alterations for the molecular classifications

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories